We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Attorneys Plead For New Class In Fosamax Case

Law360 (August 20, 2007, 12:00 AM EDT) -- Hoping to pursue a two-pronged campaign against Merck & Co., the attorneys involved in the Fosamax product liability litigation have asked the court to certify a class of plaintiffs apart from those who claim to have suffered painful deterioration of the jaw after taking the osteoporosis medication.

On Friday, lead plaintiffs' attorney Timothy O'Brien filed a class certification motion, urging the court to allow the Fosamax patients who have yet to develop osteonecrosis of the jaw to collectively pursue their request for a dental monitoring program....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.